(CRMD) CorMedix - Performance 110.9% in 12m
Compare CRMD with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
41.50%
#33 in Group
Rel. Strength
93.67%
#505 in Universe
Total Return 12m
110.87%
#15 in Group
Total Return 5y
194.85%
#19 in Group
P/E -
(?) Percentile in Group
P/E Forward 13.4
36th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -8.67%
(?) Percentile in Group
12m Total Return: CRMD (110.9%) vs XLV (-4.1%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
1.26% | 181% | 420% | 58.1 | 44.4 | 0.61 | 48.6% | 9.63% |
| LLY NYSE Eli Lilly |
3.47% | -2.41% | 404% | 67 | 36.6 | 1.33 | 58.2% | 18.9% |
| NVS NYSE Novartis |
8.01% | 14.6% | 64.6% | 17.9 | 13.9 | 1.36 | 8.40% | 9.2% |
| NOVN SW Novartis |
2.79% | 4.23% | 40.3% | 19.3 | 13.9 | 1.32 | 9.80% | 11.2% |
| SOBI ST Swedish Orphan Biovitrum |
12% | 5.01% | 48.3% | 25.6 | 20.9 | 1.61 | 16.1% | 29% |
| SAN PA Sanofi |
-1.52% | 2.67% | 20.4% | 19.2 | 11.7 | 0.88 | -16.5% | 12.2% |
| IPN PA Ipsen |
1.81% | -12.6% | 57.8% | 23.3 | 9.65 | 0.69 | -6.40% | -6.33% |
| SUPN NASDAQ Supernus Pharmaceuticals |
2.94% | 0.77% | 35.3% | 24.6 | 20.2 | 1.47 | -5.90% | -17% |
Performance Comparison: CRMD vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for CRMD
| Total Return (including Dividends) | CRMD | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 77.17% | 0.87% | 13.81% |
| 3 Months | 16.91% | -7.96% | -6.30% |
| 12 Months | 110.87% | -4.06% | 10.65% |
| 5 Years | 194.85% | 43.49% | 107.77% |
| Trend Score (consistency of price movement) | CRMD | XLV | S&P 500 |
| 1 Month | 94.8% | -8.1% | 83% |
| 3 Months | -37.8% | -75.3% | -75.3% |
| 12 Months | 66.2% | -28.8% | 50.1% |
| 5 Years | -5.50% | 89.7% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #7 | 75.6% | 55.7% |
| 3 Month | #82 | 27.0% | 24.8% |
| 12 Month | #14 | 120% | 90.6% |
| 5 Years | #20 | 105% | 41.9% |
FAQs
Does CRMD CorMedix outperforms the market?
Yes,
over the last 12 months CRMD made 110.87%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.06%.
Over the last 3 months CRMD made 16.91%, while XLV made -7.96%.
Over the last 3 months CRMD made 16.91%, while XLV made -7.96%.
Performance Comparison CRMD vs Indeces and Sectors
CRMD vs. Indices CRMD is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 23.5% | 63.4% | 8.65% | 100% |
| US NASDAQ 100 | QQQ | 23.3% | 59.8% | 8.44% | 99.2% |
| US Dow Jones Industrial 30 | DIA | 23.1% | 67.2% | 8.94% | 103% |
| German DAX 40 | DAX | 23.5% | 62.2% | -17.6% | 85.2% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 21.3% | 65.3% | 7.88% | 104% |
| Hongkong Hang Seng | HSI | 20.3% | 57.2% | 0.29% | 97.2% |
| India NIFTY 50 | INDA | 28.4% | 72.3% | 8.21% | 111% |
| Brasil Bovespa | EWZ | 22.4% | 59.9% | -0.05% | 119% |
CRMD vs. Sectors CRMD is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 22.8% | 63.8% | 1.59% | 89.3% |
| Consumer Discretionary | XLY | 23.1% | 62.9% | 9.63% | 96.6% |
| Consumer Staples | XLP | 24.3% | 70.6% | 1.72% | 102% |
| Energy | XLE | 23.7% | 70.4% | 15.2% | 120% |
| Financial | XLF | 22.4% | 63.7% | 1.55% | 88.4% |
| Health Care | XLV | 26.5% | 76.3% | 13.6% | 115% |
| Industrial | XLI | 21.8% | 60.4% | 7.22% | 99.9% |
| Materials | XLB | 23.7% | 63.6% | 13.5% | 116% |
| Real Estate | XLRE | 24.8% | 65.6% | 7.90% | 95.4% |
| Technology | XLK | 22.4% | 56.0% | 11.5% | 104% |
| Utilities | XLU | 23.4% | 67.6% | 0.99% | 93.4% |
| Aerospace & Defense | XAR | 21.5% | 56.0% | -2.85% | 83.5% |
| Biotech | XBI | 30.1% | 65.4% | 28.8% | 123% |
| Homebuilder | XHB | 23.0% | 65.7% | 21.8% | 118% |
| Retail | XRT | 21.6% | 62.5% | 12.9% | 112% |